HOXB2 and FOXC1 synergistically drive the progression of Wilms tumor.


Journal

Experimental and molecular pathology
ISSN: 1096-0945
Titre abrégé: Exp Mol Pathol
Pays: Netherlands
ID NLM: 0370711

Informations de publication

Date de publication:
08 2020
Historique:
received: 05 04 2020
revised: 10 05 2020
accepted: 17 05 2020
pubmed: 24 5 2020
medline: 30 10 2020
entrez: 24 5 2020
Statut: ppublish

Résumé

To uncover the expression patterns of HOXB2 and FOXC1 in Wilms tumor samples, and their synergistical regulations on the development of Wilms tumor. Expression levels of HOXB2 and FOXC1 in 58 cases of Wilms tumor tissues and paracancerous ones were detected. The influences of HOXB2 and FOXC1 on prognosis in Wilms tumor patients were analyzed. Their regulatory effects on proliferative and migratory abilities in WT-CLS1 and HFWT cells were examined by cell counting kit-8 (CCK-8) and Transwell assay, respectively. The interaction between HOXB2 and FOXC1, and their synergistical regulation on the development of Wilms tumor were finally explored. HOXB2 and FOXC1 were upregulated in Wilms tumor tissues. Higher levels of HOXB2 and FOXC1 indicated higher risks of advanced stage and lymphatic metastasis, as well as worse prognosis in Wilms tumor patients. Knockdown of HOXB2 or FOXC1 weakened proliferative and migratory abilities in WT-CLS1 and HFWT cells, while the opposite trends were observed in those overexpressing HOXB2 or FOXC1. The positive interaction between HOXB2 and FOXC1 was identified, which synergistically drove the malignant development of Wilms tumor. HOXB2 and FOXC1 are upregulated in Wilms tumor samples, and they are closely linked to tumor staging and lymphatic metastasis in Wilms tumor patients. HOXB2 and FOXC1 synergistically drive the malignant development of Wilms tumor by stimulating proliferative and migratory potentials.

Identifiants

pubmed: 32445751
pii: S0014-4800(20)30347-6
doi: 10.1016/j.yexmp.2020.104469
pii:
doi:

Substances chimiques

3' Untranslated Regions 0
FOXC1 protein, human 0
Forkhead Transcription Factors 0
HOXB2 protein, human 0
Homeodomain Proteins 0
Transcription Factors 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

104469

Informations de copyright

Copyright © 2020 Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declared no conflict of interest.

Auteurs

Peng Jing (P)

Department of Pediatric Surgery, Affiliated Hospital of North Sichuan Medical College, Nanchong, China; Department of Clinical Medicine, North Sichuan Medical College, Nanchong, China. Electronic address: pengji19700512@163.com.

Jiaqiong Zou (J)

Department of Medical Laboratory, the First Affiliated Hospital of Chengdu Medical College, Chengdu, China.

Lixin Zhang (L)

Department of Hepatobiliary Surgery, Affiliated Hospital of North Sichuan Medical College, Nanchong, China; Institute of Hepatobiliary, Pancreatic and Intestinal Diseases, North Sichuan Medical College, Nanchong, China.

Cheng Wang (C)

Department of Pediatric Surgery, Affiliated Hospital of North Sichuan Medical College, Nanchong, China.

Yuanbo Yang (Y)

Department of Pediatric Surgery, Affiliated Hospital of North Sichuan Medical College, Nanchong, China.

Lin Deng (L)

Department of Pediatric Surgery, Affiliated Hospital of North Sichuan Medical College, Nanchong, China.

Dan Zhao (D)

Department of Pediatric Surgery, Affiliated Hospital of North Sichuan Medical College, Nanchong, China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH